How Borage Oil Interacts with Weight-Loss Medications
Use caution · The honest verdict
Worth a conversation with your clinician
Borage oil has no documented pharmacokinetic interaction with semaglutide or tirzepatide, but its high gamma-linolenic acid (GLA) content may have mild antiplatelet effects that become relevant if a patient is also on anticoagulants or antiplatelets — the GLP-1 drug itself is not the concern; the co-medication stack is.
Borage oil, extracted from the seeds of the Borago officinalis plant, is the richest plant source of gamma-linolenic acid (GLA), an omega-6 fatty acid with anti-inflammatory properties. While it does not directly interact with GLP-1 medications like semaglutide or tirzepatide, its mild blood-thinning effects can compound with prescription anticoagulants or antiplatelet drugs common in patients with metabolic syndrome. The most critical safety issue, often overlooked, is the potential contamination of uncertified products with pyrrolizidine alkaloids (PAs), which are toxic to the liver.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Why they interact
Here's what actually happens when Borage Oil meets Anticoagulants and antiplatelet drugs (borage oil's GLA content may inhibit platelet aggregation, potentially enhancing bleeding risk with warfarin, aspirin, clopidogrel); phenothiazines and other seizure-threshold-lowering drugs (borage seed oil contains pyrrolizidine alkaloids in non-certified products that may have hepatotoxic or pro-convulsant effects); no documented pharmacokinetic interaction with semaglutide or tirzepatide — in plain language.
Borage oil is extracted from the seeds of Borago officinalis and is the richest plant source of gamma-linolenic acid (GLA), containing approximately 20–26% GLA by weight. GLA is an omega-6 fatty acid that is converted in the body to dihomo-gamma-linolenic acid (DGLA), a precursor to anti-inflammatory prostaglandins of the 1-series; this is the proposed mechanism behind borage oil's use in inflammatory conditions (eczema, rheumatoid arthritis). The GLP-1-specific interaction context involves two primary concerns: (1) Antiplatelet activity — GLA and its metabolite DGLA reduce thromboxane A2 synthesis and may inhibit platelet aggregation; when stacked with prescribed anticoagulants (warfarin, heparin) or antiplatelet agents (aspirin, clopidogrel, prasugrel) — drugs common in GLP-1 patients with metabolic syndrome and cardiovascular disease — this creates an additive bleeding risk. (2) Pyrrolizidine alkaloid (PA) contamination — crude borage seed oil products (not certified PA-free) can contain hepatotoxic and potentially pro-convulsant PAs; certified PA-free products are available but consumers must verify this on the label. GLP-1 drugs themselves (semaglutide, tirzepatide) are cleared by dipeptidyl peptidase IV and neutral endopeptidases — not CYP450 — so GLA's modest fatty acid metabolism does not affect GLP-1 pharmacokinetics. The GI burden concern: borage oil at higher doses (2–3 g/day) may cause GI discomfort (loose stools, belching), additive with GLP-1-related nausea.
What the research says
GLA antiplatelet activity is documented in preclinical and small human studies; pyrrolizidine alkaloid hepatotoxicity in uncertified borage products is documented in case reports and mentioned by the European Medicines Agency and NIH NCCIH; no direct GLP-1 co-administration studies exist for borage oil; GI tolerability data is available from inflammatory condition trials.
When and how to take it
Use only PA-free certified borage oil products; disclose to prescriber and pharmacist if on warfarin, aspirin, or any antiplatelet/anticoagulant; take with food to minimize GI effects; stop borage oil at least 7–10 days before elective surgery due to antiplatelet potential; monitor INR if on warfarin; during GLP-1 dose-escalation, reduce dose or pause borage oil if GI effects compound.
Signs to watch for
- Easy bruising or prolonged bleeding from cuts (antiplatelet additive effect with co-medications)
- Nausea, loose stools, or belching at higher doses (GI stacking with GLP-1)
- Jaundice, dark urine, or right upper quadrant pain (hepatotoxicity from PA-contaminated products — seek care immediately)
- Unexplained INR elevation if on warfarin
What to do about it
Practical, non-prescriptive steps — the specifics still belong to you and your clinician.
Verify your borage oil supplement is certified PA-free by a third-party testing organization.
Disclose borage oil use to your prescriber and pharmacist, especially if you take warfarin, aspirin, clopidogrel, or any other blood thinner.
Start with a low dose (e.g., 500 mg GLA/day) and take it with a meal to assess GI tolerability, particularly during the first 12–20 weeks of GLP-1 therapy.
Stop borage oil at least 7–10 days before any scheduled surgery and inform your surgical team.
Seek immediate medical attention if you develop signs of liver injury, such as jaundice, dark urine, or severe upper abdominal pain.
What Borage Oil Is and Why GLA Makes It Different from Other Omega-6 Oils
Borage oil isn't your standard omega-6 supplement. Pressed from the seeds of the starflower plant (Borago officinalis), it's the single richest plant source of gamma-linolenic acid (GLA), a unique fatty acid that behaves very differently from the linoleic acid found in corn or soybean oil.
By weight, borage oil is roughly 20–26% GLA, alongside about 35–38% linoleic acid and 16–20% oleic acid. The magic of GLA lies in its ability to bypass the body's rate-limiting delta-6-desaturase enzyme. This means it converts directly to dihomo-gamma-linolenic acid (DGLA), which then feeds into the production of anti-inflammatory 1-series prostaglandins. This is the opposite pathway of arachidonic acid, which produces pro-inflammatory 2-series prostaglandins.
People in GLP-1 weight-loss communities often turn to borage oil for its anti-inflammatory potential, seeking relief from obesity-related joint pain or inflammatory skin conditions like eczema. Compared to other GLA sources, borage oil is more concentrated than evening primrose oil (which contains about 8–10% GLA) and lacks the stearidonic acid (an omega-3 precursor) found in black currant seed oil. This makes borage oil a potent, targeted GLA supplement, but that potency also amplifies its systemic effects, including the antiplatelet activity we'll discuss next.
Bottom line
Borage oil's GLA content distinguishes it from standard omega-6 oils — it acts through an anti-inflammatory prostaglandin pathway, but that same pathway has antiplatelet downstream effects that become clinically relevant with co-medications.
The Antiplatelet Problem — Why Borage Oil Requires a Medication Review
The same GLA-to-DGLA pathway that reduces inflammation also quietly inhibits platelet aggregation. DGLA competes with arachidonic acid and reduces the synthesis of thromboxane A2, a molecule that helps platelets clump together to form clots. On its own, this effect is mild and unlikely to cause problems in a healthy person.
The risk emerges when borage oil is stacked with prescription medications that also impair clotting. This is a common scenario for patients on GLP-1 drugs, who often have metabolic syndrome, type 2 diabetes, or established cardiovascular disease. Many are on low-dose aspirin, clopidogrel, or even warfarin. In these cases, borage oil's antiplatelet action is additive, not just theoretical. Case reports for similar GLA-rich oils have documented elevated INR levels in patients on warfarin.
This is not a GLP-1 drug interaction. Semaglutide and tirzepatide do not affect platelet function. The concern is entirely about the co-medication stack. If you are on any blood thinner, a pharmacist-led medication review before starting borage oil is the correct first step. You should also plan to stop borage oil at least 7–10 days before any elective surgery, a precaution similar to the guidance for high-dose fish oil.
Bottom line
Borage oil is not risky in isolation — the risk is almost entirely about the rest of the medication stack; a pharmacist medication review before starting borage oil is the correct first step for any GLP-1 patient on cardiovascular drugs.
Pyrrolizidine Alkaloids — The Product Quality Issue Competitors Don't Mention
Here is the safety concern that separates borage oil from nearly every other fatty acid supplement: pyrrolizidine alkaloid (PA) contamination. PAs are naturally occurring toxins found in the leaves and seeds of the borage plant. They are hepatotoxic, meaning they can damage the liver, and in sufficient quantities, they can cause veno-occlusive disease — a serious condition where the small veins in the liver become blocked.
This is not a hypothetical risk. The European Medicines Agency and the NIH's National Center for Complementary and Integrative Health (NCCIH) have both flagged the danger of PA-contaminated borage products. Documented case reports exist of liver injury from uncertified borage oil. The critical distinction is that this is a product quality issue, not a dose-response issue with GLA itself. Reputable manufacturers now use processes to remove PAs and certify their products as PA-free.
Your job as a consumer is to read the label. Look for a clear 'PA-free' or 'pyrrolizidine alkaloid-free' claim, ideally backed by third-party testing from organizations like USP, NSF, or ConsumerLab. If the product does not explicitly state it is PA-free, assume it is not. The price difference between certified and uncertified products is negligible compared to the risk of liver injury. This is the single most important safety step, and it is almost never mentioned in generic supplement guides.
Bottom line
PA contamination is the reason borage oil product selection matters — certified PA-free products are available and are the only ones that should be used; competitors rarely surface this distinction.
GI Tolerability of Borage Oil During GLP-1 Dose Escalation
Even a high-quality, PA-free borage oil can cause digestive upset, and this matters a great deal when you're already navigating the GI side effects of a GLP-1 drug. At therapeutic doses providing 2–3 grams of GLA per day, borage oil is known to cause loose stools, belching, and general GI discomfort in some people.
This creates an additive burden with the well-documented nausea, vomiting, and diarrhea that affect a significant portion of patients during GLP-1 dose escalation. Clinical trial data for semaglutide, for instance, shows nausea prevalence around 44%. Adding a supplement that independently causes loose stools and belching can make the titration period much harder to tolerate.
The practical solution is gradual, staggered titration. Do not start a high-dose borage oil regimen during the first month of a new GLP-1 prescription or immediately after a dose increase. Instead, wait until your GI side effects from the medication have stabilized. When you do start, begin with a low dose, such as 500 mg of GLA per day, and take it with a solid meal. Capsule forms may be slightly better tolerated than liquid oil. If GI symptoms compound, pause the borage oil — it is a supplement, not a life-sustaining medication, and it can be reintroduced later.
Bottom line
Borage oil is not the worst GI offender among supplements, but its loose-stool and belching profile adds to the already significant GI burden of GLP-1 dose escalation — gradual titration during the first 12–20 weeks is the practical harm-reduction approach.
Practical Guidance — Choosing a Safe Product and Disclosing to Your Prescriber
Using borage oil safely during GLP-1 therapy comes down to two non-negotiable steps: product verification and full medication disclosure. First, select a product that is explicitly certified PA-free by a reputable third-party testing organization. The label should state this clearly; if it doesn't, choose a different brand.
Second, tell your prescriber and your pharmacist that you are taking or plan to take borage oil. Do not assume it is irrelevant because it's 'just an omega-6.' Specifically disclose any use of anticoagulants (warfarin, heparin), antiplatelet drugs (aspirin, clopidogrel, prasugrel), or medications that lower the seizure threshold. The standard therapeutic dose range for inflammatory conditions is 1–3 grams of GLA per day, which can require 5–15 grams of actual borage oil depending on the product's GLA concentration. Start at the low end and only increase if needed.
If your primary goal is general anti-inflammatory support, consider whether borage oil is truly necessary. High-quality fish oil provides EPA and DHA with a much larger body of evidence for cardiovascular and anti-inflammatory benefits, without the PA contamination risk. Flaxseed oil offers alpha-linolenic acid (ALA) for a plant-based omega-3 alternative. Borage oil has a specific, narrow niche for GLA-responsive conditions, and it should be used with precision, not as a general wellness supplement.
Bottom line
PA-free certification and pharmacist medication review are the two non-negotiable steps before using borage oil during GLP-1 therapy — the drug itself is not the interaction concern; the co-medication stack and product quality are.
What most pages leave out
Competitors either ignore borage oil entirely in GLP-1 content or list it as a generally safe omega-6 oil without distinguishing it from fish oil or flaxseed; the pyrrolizidine alkaloid contamination issue in uncertified products is almost never surfaced in consumer content — this page makes PA-free certification and co-medication review the central safety messages.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There is no direct pharmacokinetic interaction between borage oil and semaglutide. However, you must disclose borage oil use to your prescriber if you are also taking warfarin, aspirin, or any antiplatelet drug, as GLA can add to their blood-thinning effects.
No, there is no pharmacokinetic interaction with tirzepatide. The safety concerns are identical to those with semaglutide: additive antiplatelet effects with co-medications and the risk of pyrrolizidine alkaloid contamination in uncertified products.
Yes, the GLA in borage oil may inhibit platelet aggregation and can have an additive effect with warfarin, potentially raising your INR. If you are on warfarin, more frequent INR monitoring is prudent when starting or stopping borage oil, and you should stop taking it 7–10 days before any surgery.
It can. At higher doses providing 2–3 grams of GLA per day, borage oil is known to cause loose stools, belching, and GI discomfort. This can compound the nausea and diarrhea that are common during GLP-1 dose escalation. It's best to start with a low dose and titrate up slowly once your GI side effects have stabilized.
No. Pyrrolizidine alkaloids (PAs) are hepatotoxic compounds that can cause serious liver damage. You should only use borage oil products that are explicitly certified as PA-free by a reputable third-party testing organization. If the label does not state it is PA-free, do not use the product.
Both are sources of GLA and carry a similar antiplatelet caution. However, evening primrose oil has a longer safety track record at therapeutic doses and does not carry the pyrrolizidine alkaloid contamination risk that is specific to uncertified borage oil. If you need a GLA supplement, evening primrose oil is generally the lower-risk starting point.
There is no established GLP-1-specific dose. The standard therapeutic range for inflammatory conditions is 1–3 grams of GLA per day. The key to safety is not the dose alone, but using a PA-free certified product and disclosing all your medications to your prescriber and pharmacist.
GLA has some evidence for reducing inflammation in conditions like eczema and rheumatoid arthritis. However, fish oil (EPA/DHA) has much stronger and broader evidence for anti-inflammatory benefits without the PA contamination risk. Weigh the specific, narrow benefit of GLA against the product quality risks of borage oil.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
How Fish Oil / Omega-3 Fatty Acids Interacts With Weight Loss Medications
Fish oil has no direct drug interaction with semaglutide or tirzepatide, but GI upset and high-dose antiplatelet effects matter. A practical, honest guide.
Read moreHow Flaxseed Oil Interacts with Weight-Loss Medications
Flaxseed oil has no direct interaction with GLP-1s, but its antiplatelet effect warrants caution with blood thinners. Learn why ALA isn't a substitute for fish oil.
Read moreHow MCT Oil (Medium Chain Triglycerides) Interacts with Weight Loss Medications
MCT oil can worsen diarrhea and cramping from GLP-1 meds like semaglutide. Learn why the GI risks compound, and how to use it safely if you choose to.
Read moreHow Black Currant Seed Oil Interacts with Weight-Loss Medications
Black currant seed oil has no documented interaction with semaglutide or tirzepatide, but its GLA content poses a theoretical bleeding risk if you're on blood thinners. Get the honest, evidence-based details.
Read moreHow Evening Primrose Oil Interacts with Weight-Loss Medications
Evening primrose oil can increase bleeding risk and lower the seizure threshold. Learn how GLP-1 meds affect absorption and why caution is warranted.
Read moreHow Hemp Oil Interacts With Weight-Loss Medications
Hemp seed oil has no direct GLP-1 interaction, but antiplatelet effects and CBD confusion matter. Learn the real risks and what to tell your doctor.
Read moreOn a GLP-1, or thinking about one?
If you take Borage Oil alongside a GLP-1, it helps to have your medication managed by a clinician who sees the whole picture.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
Important: This page is general information, not medical advice, and it does not account for your health or medications. Supplements can interact with prescription drugs in ways that depend on your dose and situation. Curex offers compounded GLP-1 medications through licensed clinicians — compounded medications are not FDA-approved, and the FDA has not evaluated their safety or efficacy. The supplement discussed here is not a Curex product. Always talk to your pharmacist or prescriber before combining a supplement with any weight-loss medication.
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.